Clin2
NCT07153744Possibly a fitNot yet recruiting

Chinese medicine for recent heart attack

Acute Myocardial Infarction (AMI)Percutaneous Coronary Intervention (PCI)

Treatments studied

Part of Heart & circulation clinical trials.

This trial adds a Chinese medicine (Shexiang Baoxin Pill) to standard care for people having a heart attack, to see if it improves recovery when taken alongside the usual artery-opening procedure. It may help speed up heart recovery and reduce further damage.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
9,588 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have had a heart attack
  • Your symptoms started less than 24 hours before your doctor sees you
  • You are planning to have a procedure (PCI) to open a blocked artery in your heart
  • You are not allergic to the study medicine, Shexiang Baoxin Pills

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07208006Recruiting
Early cholesterol-lowering drug after heart attack

This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.

Shanghai, Shanghai Municipality
NCT07776288Not yet recruiting· Phase 2
Antioxidant therapy after a first heart attack

This trial tests whether giving a combination of antioxidant vitamins (supplements) during emergency treatment for a first heart attack can reduce heart muscle damage and improve recovery. You might be eligible if you are having an emergency angioplasty for a recent heart attack.

Santiago, Santiago Metropolitan
NCT07306182Recruiting· Phase 2
Testing SGC001 for anterior wall heart attack

This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.

Shanghai, Shanghai Municipality
NCT05466968Not yet recruiting· Phase 4
Suxiao Jiuxin pill for stabilizing vulnerable plaques in heart attack

This trial is testing whether a traditional Chinese medicine called Suxiao Jiuxin Pill, when added to standard emergency heart attack treatment (coronary angiography and stenting), can help make the fatty plaques inside your heart arteries more stable and reduce the risk of further heart problems. It's a phase 4 study, meaning the medicine is already used in practice, and this trial aims to gather more evidence on its benefits for people having a heart attack.

Jinan
NCT07621107Not yet recruiting· Phase 2
Guanxinning tablet to improve heart blood flow after a heart attack

This study tests whether a traditional Chinese medicine called Guanxinning Tablet can help improve blood flow in the tiny vessels of the heart after a heart attack treated with a stent. It may help your heart recover better and reduce future heart problems.

NCT06699407Not yet recruiting· Phase 4
Herbal treatment for heart recovery after a heart attack

This trial tests a Chinese herbal medicine called Qishenyiqi to see if it helps the heart recover and remodel (repair its shape) after a heart attack. It is for people whose heart is still weak (pumping less than 40%) and who have heart failure symptoms.

Jinan, Shandong

Hear when a new Acute Myocardial Infarction (AMI) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.